Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease

Manali Mukherjee, Parameswaran Nair

Source: Eur Respir Monogr 2022; 95: 219-237

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Manali Mukherjee, Parameswaran Nair. Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease. Eur Respir Monogr 2022; 95: 219-237

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Possible role of IL-25 in eosinophilic lung inflammation in patients with eosinophilic pneumonia
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017

Eosinophils and eosinophilic immune dysfunction in health and disease
Source: Eur Respir Rev, 31 (163) 210150; 10.1183/16000617.0150-2021
Year: 2022

The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017

Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Eicosanoids and eosinophilic inflammation of airways in stable COPD.
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018

Inflammatory cell activation in eosinophilic and non-eosinophilic asthma
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006

Cytokines profile in granulomatous lung disorders
Source: Eur Respir J 2005; 26: Suppl. 49, 374s
Year: 2005

Neutrophils in chronic inflammatory airway diseases: can we target them and how?
Source: Eur Respir J 2010; 35: 467-469
Year: 2010

Biomarkers of eosinophilic inflammation
Source: Eur Respir Monogr 2022; 95: 37-50
Year: 2022

Targeting TNF-alpha in inflammatory lung diseases
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005

IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease
Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019
Year: 2021

IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021

Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Characteristics of inflammatory bowel diseases-associated interstitial lung diseases
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
Source: ERJ Open Res, 6 (4) 00481-2020; 10.1183/23120541.00481-2020
Year: 2020